Yelena Y. Janjigian, MD | Authors

Articles

The Importance of Testing for MSI Status in Gastric Cancers

May 07, 2018

Yelena Y. Janjigian, MD, a medical oncologist at Memorial Sloan Kettering Cancer Center, discusses the importance of testing for microsatellite instability-high (MSI-H) status in patients with gastric cancers.

Nivolumab With or Without Ipilimumab in Gastroesophageal Junction Cancer

June 22, 2017

Yelena Y. Janjigian, MD, attending physician, Memorial Sloan Kettering Cancer Center, discusses findings of CheckMate-032, a study of nivolumab (Opdivo) with or without ipilimumab (Yervoy) in patients with advanced/metastatic chemotherapy-refractory gastric, esophageal, or gastroesophageal junction cancer.